Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease

ARUK Consortium, Sims, Rebecca, GERAD/PERADES, CHARGE, ADGC, EADI, van der Lee, Sven J, Naj, Adam C, Bellenguez, Céline, Badarinarayan, Nandini, Jakobsdottir, Johanna +443 more·2017·Nature Genetics
DOI 10.1038/ng.3916

Cited by (1,043)

Items 501–600 of 1,043

  1. Alterations in T-Cell Transcription Factors and Cytokine Gene Expression in Late-Onset Alzheimer’s Disease
    Masoud Neshan, Seyed Kazem Malakouti, Leila Kamalzadeh, Mina Makvand, Arezoo Campbell, Ghasem Ahangari · 2021 · Journal of Alzheimer s Disease
  2. Untangling the Role of TREM2 in Conjugation with Microglia in Neuronal Dysfunction: A Hypothesis on a Novel Pathway in the Pathophysiology of Alzheimer’s Disease
    SK Chand Basha, Mekala Janaki Ramaiah, K. S. Jagannatha Rao · 2023 · Journal of Alzheimer s Disease
  3. A functional variant of SHARPIN confers increased risk of late-onset Alzheimer’s disease
    Asanomi, Yuya, Shigemizu, Daichi, Akiyama, Shintaro, Miyashita, Akinori, Mitsumori, Risa, Hara, Norikazu, Ikeuchi, Takeshi, Niida, Shumpei, Ozaki, Kouichi · 2022 · Journal of Human Genetics
  4. Deletion of Abi3/Gngt2 influences age-progressive amyloid β and tau pathologies in distinctive ways
    Ibanez, Kristen R., McFarland, Karen N., Phillips, Jennifer, Allen, Mariet, Lessard, Christian B., Zobel, Lillian, De La Cruz, Elsa Gonzalez, Shah, Shivani, Vo, Quan, Wang, Xue et al. · 2022 · Alzheimer's Research & Therapy
  5. Intravesical BCG and Incidence of Alzheimer Disease in Patients With Bladder Cancer
    Dimitrios Makrakis, Sarah K. Holt, Charles B. Bernick, Petros D. Grivas, John L. Gore, Jonathan Lawrence Wright · 2022 · Alzheimer Disease & Associated Disorders
  6. PLCγ2 impacts microglia-related effectors revealing variants and pathways important in Alzheimer’s disease
    Li, Ke, Ran, Beibei, Wang, Yu, Liu, Lulu, Li, Weidong · 2022 · Frontiers in Cell and Developmental Biology
  7. Alzheimer’s disease: an axonal injury disease?
    Dan Liang, Zhaohui Zhang · 2023 · Frontiers in Aging Neuroscience
  8. Genome-wide association study in Alzheimer’s disease: a bibliometric and visualization analysis
    Junyao Zhang, Yinuo Wang, Yingying Zhang, Junyan Yao · 2023 · Frontiers in Aging Neuroscience
  9. Functional characterization of phospholipase C-γ2 mutant protein causing both somatic ibrutinib resistance and a germline monogenic autoinflammatory disorder
    Walliser, Claudia, Wist, Martin, Hermkes, Elisabeth, Zhou, Yuan, Schade, Anja, Haas, Jennifer, Deinzer, Julia, Désiré, Laurent, Li, Shawn S.C., Stilgenbauer, Stephan et al. · 2018 · Oncotarget
  10. Meta-analysis of the association between CD33 and Alzheimer’s disease
    Yuting Jiang, Haiyan Li, Xi‐Peng Cao, Lan Tan · 2018 · Annals of Translational Medicine
  11. TREM2 risk variants and associated endophenotypes in alzheimer’s disease
    Dijkstra, Janna I. R., Vermunt, Lisa, Venkatraghavan, Vikram, Ozhegov, Georgii, Coomans, Emma M., Ossenkoppele, Rik, van de Giessen, Elsmarieke, Hulsman, Marc, de Geus, Christa M., van der Flier, Wiesje M. et al. · 2025 · Alzheimer's Research & Therapy
  12. Genome-Wide Meta-Analysis of Late-Onset Alzheimer’s Disease Using Rare Variant Imputation in 65,602 Subjects Identifies Novel Rare Variant Locus NCK2 : The International Genomics of Alzheimer’s Project (IGAP)
    Adam Christian Naj, Ganna Leonenko, Xueqiu Jian, Benjamin Grenier‐Boley, Maria Carolina Dalmasso, Céline Bellenguez, Sha Jin, Yi Zhao, Sven J. van der Lee, Rebecca Sims et al. · 2021 · medRxiv
  13. Microglia Metabolic Breakdown Drives Alzheimer’s Pathology
    F. Chris Bennett, Shane Antony Liddelow · 2019 · Cell Metabolism
  14. ABCA7 genotype altered Aβ levels in cerebrospinal fluid in Alzheimer’s disease without dementia
    Alzheimer’s Disease Neuroimaging Initiative, Fang-Chen Ma, Yu Zong, Hui-Fu Wang, Jieqiong Li, Xi‐Peng Cao, Lan Tan · 2018 · Annals of Translational Medicine
  15. Alternative Splicing Regulation of Low-Frequency Genetic Variants in Exon 2 of TREM2 in Alzheimer’s Disease by Splicing-Based Aggregation
    Seonggyun Han, Yirang Na, InSong Koh, Kwangsik T. Nho, Younghee Lee · 2021 · International Journal of Molecular Sciences
  16. Ranking the risk factors for Alzheimer’s disease; findings from the UK Biobank study
    Michael Allwright, Hamish D. Mundell, Andrew N. McCorkindale, Richard I. Lindley, Paul J. Austin, Boris Guennewig, Greg Trevor Sutherland · 2023 · Aging Brain
  17. Probability of Alzheimer’s disease based on common and rare genetic variants
    Valentina Escott‐Price, Karl Michael Schmidt · 2021 · Alzheimer s Research & Therapy
  18. Neuroimmune interactions in Alzheimer's disease—New frontier with old challenges?
    Stefan Prokop, Virginia M.‐Y. Lee, John Q. Trojanowski · 2019 · Progress in molecular biology and translational science
  19. Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer’s Disease
    Li, Huiyue, for the Alzheimer’s Disease Neuroimaging Initiative, Liu, Hongliang, Lutz, Michael W., Luo, Sheng · 2023 · Journal of Alzheimer's Disease
  20. TREM2 variants in neurodegenerative disorders in the Polish population. Homozygosity and compound heterozygosity in FTD patients
    Beata Pepłońska, Mariusz Berdyński, Monika Mandecka, Anna K. Barczak, Magdalena Kuźma‐Kozakiewicz, Maria Barcikowska, Cezary Żekanowski · 2018 · Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
  21. Application of CRISPR/Cas9 System in the Treatment of Alzheimer’s Disease and Neurodegenerative Diseases
    Araz Rahimi, Parsa Sameei, Sana Mousavi, Kimia Ghaderi, Amin Hassani, Sepideh Hassani, Shahriar Alipour · 2024 · Molecular Neurobiology
  22. Mapping the genetic landscape of early-onset Alzheimer’s disease in a cohort of 36 families
    Merel O. Mol, Sven J. van der Lee, Marc Hulsman, Yolande A.L. Pijnenburg, Philip Scheltens, Netherlands Brain Bank, Harro Seelaar, John Cornelis Van Swieten, Laura Donker Kaat, Henne H. Holstege et al. · 2022 · Alzheimer s Research & Therapy
  23. PLCG2 modulates TREM2 expression and signaling in response to Alzheimer's disease pathology
    Messenger, Evan J., Baar, Sydney A., Bedford, Logan M., Tsai, Andy P., Lin, Peter Bor‐Chian, Ferguson, Chloe A., Xu, Guixiang, Wallace, Abigail, Landreth, Gary E., Lamb, Bruce T. et al. · 2025 · Alzheimer's & Dementia
  24. Whole-exome sequencing analysis identifies risk genes for schizophrenia
    Sophie L Chick, Peter Holmans, Darren Cameron, Detelina Grozeva, Rebecca Sims, Julie H. Williams, Nicholas J. Bray, Michael John Owen, Michael C. O’Donovan, James Walters et al. · 2025 · Nature Communications
  25. Immunological aspects of central neurodegeneration
    Mireia Niso‐Santano, José Manuel Fuentes, Lorenzo Galluzzi · 2024 · Cell Discovery
  26. Whole-genome sequencing reveals new Alzheimer’s disease-associated rare variants in loci related to synaptic function and neuronal development
    2020
  27. Genetic variants in glutamate-, Aβ−, and tau-related pathways determine polygenic risk for Alzheimer's disease
    Ted Lawingco, Sultan Raja Chaudhury, Keeley J. Brookes, Tamar Guetta‐Baranes, Rita João Guerreiro, José Brás, John Hardy, Paul T. Francis, Alan J. Thomas, Olivia Belbin et al. · 2020 · Neurobiology of Aging
  28. Microglia across evolution: from conserved origins to functional divergence
    Takashi Shimizu, Marco Prinz · 2025 · Cellular and Molecular Immunology
  29. IPSC-Derived Neuronal Cultures Carrying the Alzheimer’s Disease Associated TREM2 R47H Variant Enables the Construction of an Aβ-Induced Gene Regulatory Network
    Soraia Martins, Andreas Müller‐Schiffmann, Lars Erichsen, Martina Bohndorf, Wasco Wruck, Kristel Sleegers, Christine Van Broeckhoven, Carsten Korth, James Adjaye · 2020 · International Journal of Molecular Sciences
  30. TIGAR: An Improved Bayesian Tool for Transcriptomic Data Imputation Enhances Gene Mapping of Complex Traits
    2018
  31. Identification and development of cGAS inhibitors and their uses to treat Alzheimer's disease
    Jazmín Alarcón‐Espósito, Ravi Kumar Nagiri, Li Gan, Subhash C. Sinha · 2025 · Neurotherapeutics
  32. Absence of Apolipoprotein E is associated with exacerbation of prion pathology and promotes microglial neurodegenerative phenotype
    Pankiewicz, Joanna E., Lizińczyk, Anita M., Franco, Leor A., Diaz, Jenny R., Martá-Ariza, Mitchell, Sadowski, Martin J. · 2021 · Acta Neuropathologica Communications
  33. Genetic Complexity of Early-Onset Alzheimer’s Disease
    Mahdi Ghani, Christiane Reitz, Peter St George‐Hyslop, Ekaterina A. Rogaeva · 2018 · Springer eBooks
  34. The protective PLCγ2-P522R variant mitigates Alzheimer’s disease-associated pathologies by enhancing beneficial microglial functions
    Takalo, Mari, Jeskanen, Heli, Rolova, Taisia, Kervinen, Inka, Hellén, Marianna, Heikkinen, Sami, Koivisto, Hennariikka, Jokivarsi, Kimmo, Müller, Stephan A., Koivumäki, Esa-Mikko et al. · 2025 · Journal of Neuroinflammation
  35. EIF2AK3 variants in Dutch patients with Alzheimer's disease
    Tsz Hang Wong, Sven J. van der Lee, Jeroen van Rooij, Lieke H. H. Meeter, Petra Frick, Shamiram Melhem, Harro Seelaar, M. Arfan Ikram, Annemieke J.M. Rozemüller, Henne H. Holstege et al. · 2018 · Neurobiology of Aging
  36. Metabolic and immune dysfunction of glia in neurodegenerative disorders: Focus on iPSC models
    Taisia Rõlova, Šárka Lehtonen, Gundars Goldsteins, Pinja Kettunen, Jari Koıstınaho · 2020 · Stem Cells
  37. Syk inhibitors protect against microglia-mediated neuronal loss in culture
    Timothy J.Y. Birkle, Guy Charles Brown · 2023 · Frontiers in Aging Neuroscience
  38. Association between APOE genotype and microglial cell morphology
    Courtney M. Kloske, Mary D Gearon, Erica M. Weekman, Colin B. Rogers, Ela Patel, Adam D. Bachstetter, Peter T. Nelson, Donna M. Wilcock · 2023 · Journal of Neuropathology & Experimental Neurology
  39. Carriers of the p.P522R variant in PLCγ2 have a slightly more responsive immune system
    Diks, Annieck M., Teodosio, Cristina, de Mooij, Bas, Groenland, Rick J., Naber, Brigitta A. E., de Laat, Inge F., Vloemans, Sandra A., Rohde, Susan, de Jonge, Marien I., Lorenz, Linda et al. · 2023 · Molecular Neurodegeneration
  40. Beyond memory impairment: the complex phenotypic landscape of Alzheimer’s disease
    Stathis Argyriou, John F. Fullard, Josh M. Krivinko, Donghoon Lee, Thomas S. Wingo, Aliza P. Wingo, Robert A. Sweet, Panos Roussos · 2024 · Trends in Molecular Medicine
  41. Soluble Triggering Receptor Expressed on Myeloid Cells 2 From Cerebrospinal Fluid in Sleep Disorders Related to Parkinson’s Disease
    Mingshu Mo, Yuting Tang, Lijian Wei, Jiewen Qiu, Guoyou Peng, Yuwan Lin, Miaomiao Zhou, Wei Dai, Zhiling Zhang, Xiang 'Anthony' Chen et al. · 2021 · Frontiers in Aging Neuroscience
  42. Emerging Molecular Targets in Neurodegenerative Disorders: New Avenues for Therapeutic Intervention
    Ezgı Eroglu, Nuşin HARMANCI · 2025 · Basic & Clinical Pharmacology & Toxicology
  43. TREM2 and microglial immunity in Alzheimer’s disease: mechanisms, genetics, and therapeutic opportunities
    Wang, Tianqing, Liu, Xinru, Wang, Xifeng, Hua, Fuzhou, Yan, Lei · 2026 · Frontiers in Immunology
  44. The Big Picture of Neurodegeneration: A Meta Study to Extract the Essential Evidence on Neurodegenerative Diseases in a Network-Based Approach
    Nicolas Ruffini, Susanne Klingenberg, Raoul Heese, Susann Schweiger, Susanne Gerber · 2022 · Frontiers in Aging Neuroscience
  45. Missing lnc(RNAs) in Alzheimer’s Disease?
    Rafaela Policarpo, Constantin van Outryve d’Ydewalle · 2021 · Genes
  46. Dynamic metabolic patterns tracking neurodegeneration and gliosis following 26S proteasome dysfunction in mouse forebrain neurons
    Philippine C. Geiszler, Aslihan Ugun‐Klusek, Karen Lawler, Marie‐Christine Pardon, Yuchun Ding, Li Bai, Clare A. Daykin, Dorothee P. Auer, Lynn Bedford · 2018 · Scientific Reports
  47. CpG‐related SNPs in the MS4A region have a dose‐dependent effect on risk of late–onset Alzheimer disease
    Yiyi Ma, Gyungah Jun, Jaeyoon Chung, Xiaoling Zhang, Brian W. Kunkle, Adam Christian Naj, Charles C. White, David Alan Bennett, Philip L. De Jager, Richard P Mayeux et al. · 2019 · Aging Cell
  48. Systematic Search for Novel Circulating Biomarkers Associated with Extracellular Vesicles in Alzheimer’s Disease: Combining Literature Screening and Database Mining Approaches
    David Vogrinc, Katja Goričar, Tanja Kunej, Vita Dolžan · 2021 · Journal of Personalized Medicine
  49. Rare variant aggregation in 148,508 exomes identifies genes associated with proxy dementia
    Douglas P. Wightman, Jeanne E. Savage, Christiaan de Leeuw, Iris E. Jansen, Danielle Posthuma B · 2023 · Scientific Reports
  50. Longitudinal in vivo metabolic labeling reveals tissue-specific mitochondrial proteome turnover rates and proteins selectively altered by parkin deficiency
    Kelly L. Stauch, Steven Totusek, Andrew J. Trease, L. Daniel Estrella, Katy M. Emanuel, A. Fangmeier, Howard S. Fox · 2023 · Scientific Reports
  51. Using High-Throughput Animal or Cell-Based Models to Functionally Characterize GWAS Signals
    Pierre Dourlen, Julien Chapuis, Jean‐Charles Lambert · 2018 · Current Genetic Medicine Reports
  52. Mutation burden profile in familial Alzheimer's disease cases from India
    Syama Adhikarla, Somdatta Sen, Lakshmi Narayanan Kota, Biju Viswanath, Meera Purushottam, Mathew Varghese, Sanjeev Jain, Mitradas M. Panicker, Odity Mukherjee · 2017 · Neurobiology of Aging
  53. Polygenic regression uncovers trait-relevant cellular contexts through pathway activation transformation of single-cell RNA sequencing data
    2023
  54. Microglia aggregates define distinct immune and neurodegenerative niches in Alzheimer's disease hippocampus
    Sonja Fixemer, Mónica Miranda de la Maza, Gaël Paul Hammer, Félicia Jeannelle, Sophie Schreiner, Jean‐Jacques Gérardy, Susana Boluda, Dominique Mirault, Naguib Mechawar, Michel Guy André Mittelbronn et al. · 2025 · Acta Neuropathologica
  55. Pathway Analysis Integrating Genome-Wide and Functional Data Identifies <i>PLCG2</i> as a Candidate Gene for Age-Related Macular Degeneration
    Waksmunski, Andrea R., Grunin, Michelle, Kinzy, Tyler G., Igo, Robert P., Haines, Jonathan L., Cooke Bailey, Jessica N., for the International Age-Related Macular Degeneration Genomics Consortium · 2019 · Investigative Opthalmology &amp; Visual Science
  56. Exploring the Potential of Neuroproteomics in Alzheimer's Disease
    Md. Sahab Uddin, Md. Tanvir Kabir, Md. Jakaria, Eduardo Sobarzo‐Sánchez, George Emilio Barreto, Asma Perveen, Abdul Hafeez, May Nasser Bin-Jumah, Mohamed M. Abdel‐Daim, Ghulam Md Ashraf · 2020 · Current Topics in Medicinal Chemistry
  57. Multiscale causal network models of Alzheimer’s disease identify VGF as a key regulator of disease
    Noam D. Beckmann, Wei‐Jye Lin, Minghui Wang, Ariella T. Cohain, Pei Wang, Weiping Ma, Ying‐Chih Wang, Cheng Shi Jiang, Mickaël Audrain, Phillip Comella et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  58. The unique neuropathological vulnerability of the human brain to aging
    Isidró Ferrer · 2023 · Ageing Research Reviews
  59. Paired Immunoglobulin-like Type 2 Receptor Alpha G78R variant alters ligand binding and confers protection to Alzheimer’s disease
    2018
  60. The triggering receptor expressed on myeloid cells 2–apolipoprotein E signaling pathway in diseases
    Shukai Lyu, Zhuoqing Lan, Caixia Li · 2023 · Chinese Medical Journal
  61. Association of Alzheimer’s Disease Genetic Risk Loci with Cognitive Performance and Decline: A Systematic Review
    Shea J. Andrews, G. Peggy McFall, Andrew Booth, Roger A. Dixon, Kaarin Jane Anstey · 2019 · Journal of Alzheimer s Disease
  62. Regulation of human microglial gene expression and function via RNAase-H active antisense oligonucleotides in vivo in Alzheimer’s disease
    Lina Vandermeulen, Ivana Geric, Laura Fumagalli, Mohamed Kreir, Ashley Lu, Annelies Nonneman, Jessie Premereur, Leen Wolfs, Rafaela Policarpo, Nicola Fattorelli et al. · 2024 · Molecular Neurodegeneration
  63. The Effect of Alzheimer’s Disease-Associated Genetic Variants on Longevity
    Niccoló Tesi, Marc Hulsman, Sven J. van der Lee, Iris E. Jansen, Najada Stringa, Natasja M. van Schoor, Philip Scheltens, Wiesje M. van der Flier, Martijn A. Huisman, Marcel J. T. Reinders et al. · 2021 · Frontiers in Genetics
  64. The protein kinase C modulator bryostatin-1 therapeutically targets microglia to attenuate neuroinflammation and promote remyelination
    Payam Mohammad Gharibani, Efrat Abramson, Shruthi Shanmukha, Matthew D. Smith, Wesley H. Godfrey, Judy J. Lee, Jingwen Hu, Maryna Baydyuk, Marie‐France Dorion, Xiaojing Deng et al. · 2025 · Science Translational Medicine
  65. Association of statins use and genetic susceptibility with incidence of Alzheimer's disease
    Zirong Ye, Jiahe Deng, Xiuxia Wu, Jingwen Cai, Sicheng Li, Xiaochun Chen, Jiawei Xin · 2025 · The Journal of Prevention of Alzheimer s Disease
  66. Central nervous system sulfatide deficiency as a causal factor for bladder disorder in Alzheimer's disease
    Sijia He, Shulan Qiu, Meixia Pan, Juan Pablo Palavicini, Hu Wang, Xin Li, Anindita Bhattacharjee, Savannah Barannikov, Kevin F. Bieniek, Jeffrey L. Dupree et al. · 2023 · Clinical and Translational Medicine
  67. Transplanting Microglia for Treating CNS Injuries and Neurological Diseases and Disorders, and Prospects for Generating Exogenic Microglia
    Susanna R. Var, Phoebe Strell, Sether T. Johnson, Alex Roman, Zoey Vasilakos, Walter C. Low · 2023 · Cell Transplantation
  68. Genetic variability in response to Aβ deposition influences Alzheimer’s risk
    Dervis A. M. Salih, Sevinç Bayram, Manuel Sebastian Guelfi, Regina Hertfelder Reynolds, Maryam Shoai, Mina Ryten, Jonathan Brenton, David Zhang, Mar Matarín, Juan Antonio Botía et al. · 2018 · bioRxiv (Cold Spring Harbor Laboratory)
  69. Control of microglial dynamics by Arp2/3 and the autism and schizophrenia-associated protein Cyfip1
    Drew, James, Arancibia-Carcamo, I. Lorena, Jolivet, Renaud, Lopez-Domenech, Guillermo, Attwell, David, Kittler, Josef T. · 2020
  70. Alzheimer’s disease basics: we all should know
    S.K. Das · 2025 · Neurological Research
  71. The association of clinical phenotypes to known AD/FTD genetic risk loci and their inter-relationship
    Qingqin S. Li, Chao Tian, David A. Hinds, Guy R. Seabrook · 2020 · PLoS ONE
  72. The gain-of-function TREM2-T96K mutation increases risk for Alzheimer’s disease by impairing microglial function
    Pilat, Dominika J., Le, Hoang, Prokopenko, Dmitry, Lin, Chih-Chung Jerry, Eimer, William A., Quinti, Luisa, Gavrilles, Evan P., Garcia, Sheyla N., Heitman, Sara N., McGinty, Danielle et al. · 2026 · Neuron
  73. Towards a Unitary Hypothesis of Alzheimer’s Disease Pathogenesis
    E. Area-Gómez, E. Schon · 2024 · Journal of Alzheimer's Disease
  74. Immunity in Alzheimer’s disease: From mechanisms to therapies
    Xiaoying Chen, David M. Holtzman, Marco Colonna · 2026 · Immunity
  75. Neurofilament degradation is involved in laparotomy-induced cognitive dysfunction in aged rats
    Yiyun Cao, Taotao Liu, Zhengqian Li, Yang Jiao, Lijun Ma, Xinning Mi, Ning Yang, Aihua Qi, Xiangyang Guo, Aizhong Wang · 2020 · Aging
  76. Tumor Necrosis Factor (TNF) Blocking Agents are Associated with Lower Risk for Alzheimer’s Disease in Patients with Rheumatoid Arthritis and Psoriasis
    2019
  77. Effects of Microglial Cytokines on Alzheimer’s Disease-Related Phenomena
    Yan Ji, Xiaowan Wang, Colin H. Kalicki, Blaise W. Menta, Megan Baumgardner, Scott J. Koppel, Ian W. Weidling, Judit Perez Ortiz, Heather Wilkins, Russell Howard Swerdlow · 2019 · Journal of Alzheimer s Disease
  78. Multi Layered Omics Approaches Reveal Glia Specific Alterations in Alzheimer's Disease: A Systematic Review and Future Prospects
    Özkan İş, Yuhao Min, Xue Wang, Stephanie R. Oatman, Ann Abraham Daniel, Nilüfer Ertekin‐Taner · 2024 · Glia
  79. Single-cell RNA sequencing analysis of vestibular schwannoma reveals functionally distinct macrophage subsets
    Paramita Baruah, Christopher B. Mahony, Jennifer L. Marshall, Charlotte G. Smith, Peter Monksfield, Richard M Irving, Ingrid Elena Dumitriu, Christopher Dominic Buckley, Adam P. Croft · 2024 · British Journal of Cancer
  80. Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
    2022
  81. Excessive Alcohol Use as a Risk Factor for Alzheimer’s Disease: Epidemiological and Preclinical Evidence
    Paige E. Anton, Nicole M. Maphis, David N. Linsenbardt, Leon G. Coleman · 2025 · Advances in experimental medicine and biology
  82. The Impact of Apolipoprotein E (APOE) Epigenetics on Aging and Sporadic Alzheimer’s Disease
    2023
  83. Uncovering neuroinflammation-related modules and potential repurposing drugs for Alzheimer's disease through multi-omics data integrative analysis
    Li, Shensuo, Lu, Changhao, Zhao, Zhenzhen, Lu, Dong, Zheng, Guangyong · 2023 · Frontiers in Aging Neuroscience
  84. Functional insight into LOAD-associated microglial response genes
    Lauren A. Jonas, Tanya Jain, Yue‐Ming Li · 2022 · Open Biology
  85. CD33 mRNA Has Elevated Expression Levels in the Leukocytes of Peripheral Blood in Patients with Late-Onset Alzheimer’s Disease
    Fatemeh Heidari, George Ansstas, Farzam Ajamian · 2021 · Gerontology
  86. Genetic architecture of neurodegenerative dementias
    Jordi Clarimón, Sonia Moreno–Grau, Laura Cervera‐Carles, Oriol Dols‐Icardo, Pascual Sánchez‐Juan, Agustı́n Ruiz · 2020 · Neuropharmacology
  87. Identifying significant genes and functionally enriched pathways in familial hypercholesterolemia using integrated gene co-expression network analysis
    Zuhier Ahmed Awan, Nuha Mohammad Alrayes, Zeenath Khan, Majid Almansouri, Abdulhadi Ibrahim Hussain Bima, Haifa S. Almukadi, Hussam Ibrahim Kutbi, Preetha J. Shetty, Noor Ahmad Shaik, Babajan Banaganapalli · 2022 · Saudi Journal of Biological Sciences
  88. Direct‐to‐consumer genetic testing in China and its role in GWAS discovery and replication
    Kang Kang, Xue Sun, Lizhong Wang, Xiaotian Yao, Senwei Tang, Junjie Deng, Xiaoli Wu, Can Yang, Gang Chen · 2020 · Quantitative Biology
  89. Microglia either promote or restrain TRAIL-mediated excitotoxicity caused by Aβ1−42 oligomers
    Jian Zou, Elizabeth M. McNair, Sagan DeCastro, Scott P. Lyons, Angie L. Mordant, Laura E. Herring, Ryan P. Vetreno, Leon G. Coleman · 2024 · Journal of Neuroinflammation
  90. Neuroinflammation als Motor der Alzheimer-Erkrankung
    Sergio Castro‐Gomez, Julius Binder, Michael Thomas Heneka · 2019 · Der Nervenarzt
  91. AlzCode: a platform for multiview analysis of genes related to Alzheimer’s disease
    Cuixiang Lin, Hong‐Dong Li, Chao Deng, Shannon Erhardt, Jun Wang, Xiaoqing Peng, Jianxin Wang · 2022 · Bioinformatics
  92. Neurodegenerative Disease Risk in Carriers of Autosomal Recessive Disease
    Sophia R.L. Vieira, Huw R. Morris · 2021 · Frontiers in Neurology
  93. Genome-wide meta-analysis, fine-mapping, and integrative prioritization identify new Alzheimer’s disease risk genes
    2020
  94. The protective role of miR-132 targeting HMGA2 through the PI3K/AKT pathway in mice with Alzheimer's disease.
    Xichang Liu, Haitao Wang, Jiawei Bei, Jun Zhao, Ge Jiang, Xiuhong Liu · 2021 · PubMed Central
  95. A landscape of the genetic and cellular heterogeneity in Alzheimer disease
    Logan Brase, Shih‐Feng You, Ricardo D’Oliveira Albanus, Jorge L. Del‐Aguila, Yaoyi Dai, Brenna C. Novotny, Carolina Soriano‐Tárraga, Taitea Dykstra, María Victoria Fernández, John Budde et al. · 2021 · medRxiv
  96. Neutrophil Phospholipase Cγ2 Drives Autoantibody‐Induced Arthritis Through the Generation of the Inflammatory Microenvironment
    Krisztina Futosi, Orsolya Kása, Kata P. Szilveszter, Attila Mócsai · 2021 · Arthritis & Rheumatology
  97. Innate immunity and inflammation in Alzheimer´s disease pathogenesis
    Leonel Tadao Takada · 2017 · Arquivos de Neuro-Psiquiatria
  98. Frequency of the TREM2 R47H Variant in Various Neurodegenerative Disorders
    Ariane H. Ayer, Kevin J. Wojta, Eliana Marisa Ramos, Deepika Reddy Dokuru, Jason Chen, Anna M. Karydas, John D. Papatriantafyllou, Dimitrios Agiomyrgiannakis, Vasiliki Kamtsadeli, Niki Tsinia et al. · 2019 · Alzheimer Disease & Associated Disorders
  99. Translating Alzheimer’s Disease Mechanisms into Therapeutic Opportunities
    Jiejia Li, Liyun Wang, Xiaodan Zhang, Jianhua Shi, Yi Zhun Zhu, Han Wang, Xiangyang Zhu, Qing Zhu, Jialie Luo · 2025 · Biomolecules
  100. PLCG2 rs72824905 Variant Reduces the Risk of Alzheimer’s Disease and Multiple Sclerosis
    Fan Chen, Yan Zhang, Longcai Wang, Tao Wang, Zhifa Han, Haihua Zhang, Shan Gao, Yang Hu, Guiyou Liu · 2021 · Journal of Alzheimer s Disease